New strategies for targeting kinase networks in cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference89 articles.
1. Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies;Gallaher;Cancer Res.,2018
2. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer;Duncan;Cell,2012
3. Estimation of clinical trial success rates and related parameters;Wong;Biostatistics,2019
4. Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study;Westin;Gynecol. Oncol.,2019
5. Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer;Liu;Gynecol. Oncol.,2019
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of natural product-based targeted protein degraders as anticancer agents;Bioorganic Chemistry;2024-12
2. Emerging and Biological Concepts in Pediatric High-Grade Gliomas;Cells;2024-09-05
3. Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases;Life Sciences;2024-08
4. A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance;Nature Cancer;2024-07-11
5. Oxygen tension-dependent variability in the cancer cell kinome impacts signaling pathways and response to targeted therapies;iScience;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3